Odoribacter laneus CAG:561

Information

Microbe Identification

Odoribacter laneus CAG:561

Microbe id: PMDBM2021639
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Odoribacter laneus CAG:561 [1263089]
Taxonomy Genus: Odoribacter [283168]
Taxonomy Family: Odoribacteraceae [1853231]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Odoribacter laneus CAG:561

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Odoribacter laneus CAG:561


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Odoribacter laneus CAG:561 distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Odoribacter laneus CAG:561 in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Odoribacter laneus CAG:561

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗-3.31370811187274mNGS
Diabetes Mellitus, Type 2 PRJDB9608🔗-3.5691204428134616S
Coronary Disease PRJNA818062🔗3.68409331838004mNGS
Diarrhea PRJEB14038🔗-3.2715312125245mNGS
Diarrhea PRJNA317326🔗-2.8864391273867916S
Colorectal Neoplasms PRJEB70916🔗-3.58344087452754mNGS
Colorectal Neoplasms PRJEB46665🔗-2.4052448351088616S
Colorectal Neoplasms PRJEB53415🔗2.7880957957075816S
Colorectal Neoplasms PRJNA1126038🔗3.2466299996469116S
Colorectal Neoplasms PRJNA731589🔗3.33145608287504mNGS
Colorectal Neoplasms PRJDB11845🔗3.7950769994758816S
Respiratory Syncytial Virus Infections PRJNA579491🔗2.4898882833760816S
Diabetes Mellitus, Type 1 PRJNA766410🔗3.2599391126310416S
Diabetes Mellitus, Type 1 PRJNA604850🔗3.51945262128343mNGS
Hepatitis, Autoimmune PRJNA556801🔗-3.4759426766426816S
Parkinson Disease PRJEB53403🔗3.34426694862544mNGS
Parkinson Disease PRJNA742875🔗3.4343933020929216S
Parkinson Disease PRJNA762484🔗3.49020905420575mNGS
Colitis, Ulcerative PRJNA398089🔗-3.36943193022978mNGS
Colitis, Ulcerative PRJNA993675🔗-2.86972551577425mNGS
Colitis, Ulcerative PRJNA820056🔗2.2971516100947316S
Caliciviridae Infections PRJNA788674🔗-3.4533416145211816S
Hepatolenticular Degeneration PRJNA1038771🔗-3.1263903260194616S
Osteoporosis PRJNA565497🔗2.771165400919716S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-2.9372621791476616S
Non-alcoholic Fatty Liver Disease PRJNA540738🔗-2.8335616520731716S
Emergence Delirium PRJNA797529🔗-3.154518071059116S
Crohn Disease PRJNA917086🔗-3.4099341534763716S
Crohn Disease PRJNA993675🔗-3.03538562544086mNGS
Crohn Disease PRJNA820056🔗2.5758726156250416S
Crohn Disease PRJNA793776🔗3.16086536850473mNGS
Psoriasis PRJNA938297🔗-2.61234848708229mNGS
Moyamoya Disease PRJNA917033🔗3.3735080091855116S
Diabetic Retinopathy PRJNA857030🔗3.6808229974979216S
Dermatitis, Atopic PRJEB45443🔗-2.43040448453982mNGS
Arthritis, Rheumatoid PRJNA574565🔗-3.8357440628932216S
Arthritis, Rheumatoid PRJNA786110🔗-3.4882490213344216S
Fatigue Syndrome, Chronic PRJNA751448🔗-3.44068551401898mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗3.65389800620692mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗3.71254628693624mNGS
Anorexia PRJNA674716🔗-3.11909575808918mNGS
Cholangiocarcinoma PRJNA932948🔗-3.13115525285299mNGS
Neuroblastoma PRJEB63351🔗-3.15226265944993mNGS
Hematologic Neoplasms PRJNA777832🔗-3.2917080991183616S
Irritable Bowel Syndrome PRJNA705217🔗-3.49926908729563mNGS
Irritable Bowel Syndrome PRJNA682378🔗-2.4068733264567416S
Gastroesophageal Reflux PRJNA993632🔗3.35131422623749mNGS
Clostridium Infections PRJNA648321🔗-3.33964781482681mNGS
Lung Neoplasms PRJNA736821🔗-3.4914598354693916S
Liver Cirrhosis PRJNA861246🔗2.6180390446594616S
Cystic Fibrosis PRJNA314903🔗-2.41482868222475mNGS
Obesity PRJNA815750🔗-3.5246617477103516S
Autism Spectrum Disorder PRJEB42687🔗-2.9568915862940916S
Retinal Artery Occlusion PRJEB24557🔗-3.42810171011808mNGS
Rhinitis, Allergic PRJNA718687🔗-3.7842323003207316S
Renal Insufficiency, Chronic PRJNA659589🔗-3.3634344442748716S
Renal Insufficiency, Chronic PRJEB34855🔗3.7240928271024316S
Multiple Sclerosis PRJEB28543🔗-3.68335079958886mNGS
COVID-19 PRJNA769052🔗-3.1850409351402516S
COVID-19 PRJNA624223🔗-2.80823087779711mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Odoribacter laneus CAG:561



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Odoribacter laneus CAG:561



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Odoribacter laneus CAG:561

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Odoribacter laneus CAG:561


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Odoribacter laneus CAG:561



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Odoribacter laneus CAG:561

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Odoribacter laneus CAG:561

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Odoribacter laneus CAG:561

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Odoribacter laneus CAG:561



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Odoribacter laneus CAG:561


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Odoribacter laneus CAG:561


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?